Feasibility and Benefit of Minimization and Withdrawal of Immunosuppression (IS) Early After Liver Transplantation in HCV Positive Recipients.

被引：0
|
作者：
Shaked, A. [1 ]
Feng, S. [2 ]
Punch, J. [3 ]
Reyes, J. [4 ]
Klintmalm, G. [5 ]
Zimmerman, M. [6 ]
DesMarais, M. [2 ]
Kopetskie, H. [7 ]
Priore, A. [8 ]
Bridges, N. [8 ]
Sayre, P. [2 ]
机构：
[1] Univ Penn, Philadelphia, PA 19104 USA
[2] UCSF, San Francisco, CA USA
[3] Univ Michigan, Ann Arbor, MI 48109 USA
[4] Northwestern, Chicago, IL USA
[5] Baylor, Dallas, TX USA
[6] Univ Colorado, Denver, CO 80202 USA
[7] RhoFed, Chapel Hill, NC USA
[8] NIAID, Bethesda, MD 20892 USA
来源：
TRANSPLANTATION | 2014年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
2959
引用
收藏
页码：230 / 231
页数：2
相关论文
共 50 条
  • [1] Feasibility and Benefit of Minimization and Withdrawal of Immunosuppression (IS) Early After Liver Transplantation in HCV Positive Recipients
    Shaked, A.
    Feng, S.
    Punch, J.
    Reyes, J.
    Klintmalm, G.
    Zimmerman, M.
    DesMarais, M.
    Kopetskie, H.
    Priore, A.
    Bridges, N.
    Sayre, P.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 230 - 231
  • [2] Outcomes of immunosuppression minimization and withdrawal early after liver transplantation
    Shaked, Abraham
    DesMarais, Michele R.
    Kopetskie, Heather
    Feng, Sandy
    Punch, Jeffrey D.
    Levitsky, Josh
    Reyes, Jorge
    Klintmalm, Goran B.
    Demetris, Anthony J.
    Burrell, Bryna E.
    Priore, Allison
    Bridges, Nancy D.
    Sayre, Peter H.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 (05) : 1397 - 1409
  • [3] Outcome of liver transplantation of HCV positive grafts in HCV infected recipients.
    Vargas, HE
    Laskus, T
    Wang, LF
    Radkowski, M
    Dodson, F
    Fung, JJ
    Rakela, J
    [J]. HEPATOLOGY, 1997, 26 (04) : 103 - 103
  • [4] Fibrosis Progression after Liver Transplantation in HCV Recipients: The Impact of Different Immunosuppression Treatments and Immunosuppression Withdrawal.
    Tariciotti, Laura
    Manzia, Tommaso M.
    Angelico, Roberta
    Toti, Luca
    Fazzolari, Laura
    Anselmo, Alessandro
    Tisone, Giuseppe
    [J]. LIVER TRANSPLANTATION, 2013, 19 : S147 - S147
  • [5] Development of Post-Transplant DSA Following Immunosuppression Minimization/Withdrawal in Liver Transplant Recipients.
    Jucaud, V.
    Shaked, A.
    DesMarais, M.
    Sayre, P.
    Everly, M.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 472 - 473
  • [6] Outcomes of immunosuppression minimization and withdrawal early after liver transplantation (vol 19, pg 1397, 2019)
    Shaked, A.
    DesMarais, M. R.
    Kopetskie, H.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 (08) : 2393 - 2393
  • [7] Survival Benefit of Kidney Transplantation into Crossmatch Positive Recipients.
    Segev, Dorry L.
    Lonze, Bonnie E.
    Kucirka, Lauren M.
    Zachary, Andrea A.
    Singer, Andrew L.
    Locke, Jayme E.
    Warren, Daniel S.
    Montgomery, Robert A.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 727 - 727
  • [8] The Histological Findings after Ten Years of Immunosuppression Off in Stable HCV Liver Transplant Recipients.
    Manzia, Tommaso Maria
    Angelico, Roberta
    Toti, Luca
    Ciano, Paolo
    Palmieri, Giampiero
    Tisone, Giuseppe
    [J]. LIVER TRANSPLANTATION, 2012, 18 : S88 - S88
  • [9] DCD LIVER TRANSPLANTATION IN HCV POSITIVE RECIPIENTS
    Puneet, Puoni
    Tariciotti, Laura
    Rocha, Chiara
    Buckels, John
    Muiesan, Paolo
    [J]. TRANSPLANT INTERNATIONAL, 2010, 23 : 17 - 17
  • [10] Immunosuppression in HCV-positive liver-transplant recipients
    Chan, Aaron James
    Lake, John R.
    [J]. CURRENT OPINION IN ORGAN TRANSPLANTATION, 2012, 17 (06) : 648 - 654
12345